Skip to content
10-K

Annual Report

AtriCure, Inc. ATRC

0001323885-25-000009

← back to feed
Filed
Feb 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 11, 2025 48.88M sh
Short Term Investments FY 2024 · Dec 31, 2024 $0
Short Term Investments FY 2024 · Dec 31, 2023 $52.98M
Long Term Debt FY 2024 · Dec 31, 2023 $60.59M
Cash And Equivalents FY 2024 · Dec 31, 2023 $84.31M
Current Liabilities FY 2024 · Dec 31, 2023 $74.57M
Total Liabilities FY 2024 · Dec 31, 2023 $147.76M
Current Assets FY 2024 · Dec 31, 2023 $266.25M
Total Assets FY 2024 · Dec 31, 2023 $613.93M
Shares Diluted FY 2024 · Dec 31, 2022 45.74M sh
Capex FY 2024 · Dec 31, 2022 $16.88M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$22.14M
Eps Diluted FY 2024 · Dec 31, 2022 −$1.02
Eps Basic FY 2024 · Dec 31, 2022 −$1.02
Sga Expense FY 2024 · Dec 31, 2022 $231.27M
Rd Expense FY 2024 · Dec 31, 2022 $57.34M
Net Income FY 2024 · Dec 31, 2022 −$46.47M
Operating Income FY 2024 · Dec 31, 2022 −$42.67M
Gross Profit FY 2024 · Dec 31, 2022 $245.94M
Cost Of Revenue FY 2024 · Dec 31, 2022 $84.44M
Revenue FY 2024 · Dec 31, 2022 $330.38M
Stockholders Equity FY 2024 · Dec 31, 2021 $483.76M